In the present study we sought to simultaneously profile TP53 mutations and miRNA expression in multiple liquid biopsy samples from one metastatic HNSCC patient, thereby tracing the related molecular evolution over time. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.